Intermede Investment Partners LTD Zoetis Inc. Transaction History

Intermede Investment Partners LTD

$4.79 Billion
Q3 2024

A detailed history of Intermede Investment Partners LTD transactions in Zoetis Inc. stock. As of the latest transaction made, Intermede Investment Partners LTD holds 737,624 shares of ZTS stock, worth $122 Million. This represents 3.01% of its overall portfolio holdings.

Number of Shares

737,624

Previous 751,854 1.89%

Holding current value

$122 Million

Previous $130 Million 10.57%

% of portfolio

3.01%

Previous 2.75%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$172.58 - $196.48 $2.46 Million - $2.8 Million	-14,230 Reduced 1.89%	737,624 $144 Million
Q2 2024 Jul 17, 2024	SELL	$145.54 - $178.83 $24.6 Million - $30.2 Million	-169,153 Reduced 18.37%	751,854 $130 Million
Q1 2024 May 10, 2024	SELL	$165.67 - $199.94 $9.9 Million - $11.9 Million	-59,766 Reduced 6.09%	921,007 $156 Million
Q4 2023 Feb 12, 2024	SELL	$151.44 - $200.09 $7.46 Million - $9.86 Million	-49,293 Reduced 4.79%	980,773 $194 Million
Q3 2023 Nov 08, 2023	SELL	$167.14 - $192.77 $6.84 Million - $7.89 Million	-40,926 Reduced 3.82%	1,030,066 $179 Million
Q2 2023 Aug 09, 2023	SELL	$160.94 - $186.23 $178,482 - $206,529	-1,109 Reduced 0.1%	1,070,992 $184 Million
Q1 2023 May 15, 2023	SELL	$145.48 - $175.02 $26.5 Million - $31.9 Million	-181,980 Reduced 14.51%	1,072,101 $178 Million
Q4 2022 Feb 09, 2023	BUY	$131.14 - $157.47 $25.9 Million - $31.2 Million	197,821 Added 18.73%	1,254,081 $184 Million
Q3 2022 Oct 24, 2022	SELL	$148.29 - $182.55 $5.09 Million - $6.27 Million	-34,336 Reduced 3.15%	1,056,260 $157 Million
Q2 2022 Aug 03, 2022	BUY	$155.97 - $200.09 $4.91 Million - $6.3 Million	31,472 Added 2.97%	1,090,596 $187 Million
Q1 2022 Apr 28, 2022	BUY	$181.39 - $234.03 $13.1 Million - $16.9 Million	72,150 Added 7.31%	1,059,124 $200 Million
Q4 2021 Jan 14, 2022	SELL	$193.69 - $247.03 $18.8 Million - $24 Million	-97,312 Reduced 8.97%	986,974 $241 Million
Q3 2021 Oct 27, 2021	SELL	$189.29 - $209.69 $1.7 Million - $1.88 Million	-8,968 Reduced 0.82%	1,084,286 $211 Million
Q2 2021 Jul 30, 2021	SELL	$155.9 - $187.99 $2.98 Million - $3.59 Million	-19,116 Reduced 1.72%	1,093,254 $204 Million
Q1 2021 May 07, 2021	BUY	$144.0 - $169.39 $4.92 Million - $5.79 Million	34,191 Added 3.17%	1,112,370 $175 Million
Q4 2020 Feb 05, 2021	BUY	$157.07 - $174.35 $33.3 Million - $36.9 Million	211,691 Added 24.43%	1,078,179 $178 Million
Q3 2020 Oct 29, 2020	BUY	$137.1 - $165.37 $3.13 Million - $3.77 Million	22,809 Added 2.7%	866,488 $143 Million
Q2 2020 Aug 06, 2020	BUY	$111.92 - $142.53 $2.01 Million - $2.56 Million	17,963 Added 2.18%	843,679 $116 Million
Q1 2020 May 11, 2020	BUY	$92.66 - $144.94 $6.24 Million - $9.76 Million	67,322 Added 8.88%	825,716 $97.2 Million
Q4 2019 Feb 10, 2020	BUY	$116.25 - $133.25 $1.42 Million - $1.63 Million	12,230 Added 1.64%	758,394 $100 Million
Q3 2019 Nov 01, 2019	SELL	$112.57 - $128.43 $1.01 Million - $1.15 Million	-8,955 Reduced 1.19%	746,164 $93 Million
Q2 2019 Jul 30, 2019	SELL	$97.98 - $114.28 $8.85 Million - $10.3 Million	-90,303 Reduced 10.68%	755,119 $85.7 Million
Q1 2019 May 01, 2019	BUY	$81.56 - $100.67 $8.33 Million - $10.3 Million	102,194 Added 13.75%	845,422 $85.1 Million
Q4 2018 Feb 14, 2019	BUY	$79.28 - $95.27 $2.96 Million - $3.56 Million	37,399 Added 5.3%	743,228 $63.6 Million
Q3 2018 Oct 29, 2018	BUY	$83.5 - $93.23 $2.38 Million - $2.66 Million	28,541 Added 4.21%	705,829 $64.6 Million
Q2 2018 Aug 08, 2018	BUY	$79.9 - $89.2 $13.1 Million - $14.6 Million	163,656 Added 31.86%	677,288 $57.7 Million
Q1 2018 May 01, 2018	BUY	$71.51 - $84.69 $36.7 Million - $43.5 Million	513,632 New	513,632 $42.9 Million

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.2B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intermede Investment Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Intermede Investment Partners LTD with notifications on news.

Account

Intermede Investment Partners LTD Zoetis Inc. Transaction History